Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: A 2-year, double-blind, placebo-controlled study
- 31 August 2004
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (2) , 384-390
- https://doi.org/10.1016/j.fertnstert.2004.01.033
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- IGF status is altered by tamoxifen in patients with breast cancerMolecular Pathology, 2001
- Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Serum Levels of Insulin-like Growth Factor (IGF) I, IGF-Binding Protein (IGFBP)-2, and IGFBP-3 in Osteoporotic Patients with and without Spinal FracturesJournal of Bone and Mineral Research, 1997
- Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular PhysiologyHypertension, 1997
- Metabolic Actions of Growth Hormone in Man.Endocrine Journal, 1996
- Insulin-Like Growth FactorsNeurosignals, 1992
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990